Intuitive Surgical (ISRG) Stock Price, Fundamentals & Analysis

What ISRG does

Intuitive Surgical (ISRG) is a US stock in the Healthcare sector, specifically Medical Instruments & Supplies, headquartered in Sunnyvale, United States. The company develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. Its flagship product is the da Vinci Surgical System, which enables surgical procedures using a minimally invasive approach, and it also offers the Ion endoluminal system for diagnostic endoluminal procedures. The company provides a suite of stapling, energy, and core instrumentation, progressive learning pathways, customer service and support infrastructure, and integrated digital capabilities. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical is part of the S&P 500 and operates alongside peers like Align Technology (ALGN), Idexx Laboratories (IDXX), Danaher Corporation (DHR), Regeneron Pharmaceuticals (REGN), Cigna (CI), Abbott Laboratories (ABT), and Steris (STE).

Key numbers explained

• 398.3 USD is the current share price, representing the cost to buy one share of Intuitive Surgical on the US market.
• The trailing P/E ratio of 45.6 compares the current share price to the company's last 12 months of earnings per share; a higher number can indicate investors expect strong future growth.
• The forward P/E ratio of 32.9 uses expected future earnings, offering a view of valuation based on what analysts anticipate.
• 8.73 USD is the earnings per share for the trailing 12 months, showing the portion of profit attributable to each share.
• The dividend yield is 0%, meaning Intuitive Surgical does not currently pay a dividend, and 0% of earnings are paid out as dividends.
• 142.7B USD is the market capitalisation, the total value of all outstanding shares, placing Intuitive Surgical among large-cap companies.
• 1.47 is the beta, indicating the stock's price tends to be more volatile than the overall market.
• The 52-week price range of 328.57 – 603.88 shows the lowest and highest share prices over the past year.

Recent news

Recent headlines include a comparison of Intuitive Surgical with Stryker as a medtech investment, a report on the global minimally invasive robotic surgical system market benchmarking Intuitive Surgical alongside Johnson & Johnson, Medtronic, Stryker, and Zimmer Biomet, and a piece on why Intuitive Surgical rose 6.5% after a new da Vinci SP transvaginal approval. Other stories cover Natera's Signatera approval in Japan, retaining INSP stock, and identifying beaten-down stocks to buy before a rebound.

What to watch

Investors tracking Intuitive Surgical may monitor the upcoming earnings date of 20 oct. 2026, the company's revenue growth of 18.5% year over year, and its profit margin of 28.4%. The operating margin of 33.6% and return on equity of 17.4% are also key indicators of operational efficiency. The price-to-book ratio of 7.76 and the wide 52-week price range of 328.57 – 603.88 can help frame the stock's valuation and volatility within the Healthcare sector.